Not available
Quote | Avivagen (OTCMKTS:CHEXF)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.4195 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/12/2019 09:01:25 am |
News | Avivagen (OTCMKTS:CHEXF)
Avivagen ( OTCPK:CHEXF ) on Friday proposed a C$1M stock offering in private placement priced at C$0.20 per share. The company intends to use the net proceeds "to fund research and development expenses, sales and marketing costs, product registration, interest expense, working...
Avivagen press release (OTCPK:CHEXF): Q2 GAAP EPS of -C$0.02. Revenue of C$0.09M (-43.8% Y/Y). For further details see: Avivagen GAAP EPS of -C$0.02, revenue of C$0.09M
Message Board Posts | Avivagen (OTCMKTS:CHEXF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...